rs314776

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002335.4(LRP5):​c.884-4T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 1,613,252 control chromosomes in the GnomAD database, including 139,962 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 18654 hom., cov: 29)
Exomes 𝑓: 0.39 ( 121308 hom. )

Consequence

LRP5
NM_002335.4 splice_region, intron

Scores

2
Splicing: ADA: 0.000005640
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.249

Publications

16 publications found
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
  • bone mineral density quantitative trait locus 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • exudative vitreoretinopathy 4
    Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • osteoporosis-pseudoglioma syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant osteosclerosis, Worth type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 4 with or without kidney cysts
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant osteopetrosis 1
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyperostosis corticalis generalisata
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteosclerosis-developmental delay-craniosynostosis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polycystic liver disease 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 11-68365567-T-C is Benign according to our data. Variant chr11-68365567-T-C is described in ClinVar as Benign. ClinVar VariationId is 258642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.687 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP5NM_002335.4 linkc.884-4T>C splice_region_variant, intron_variant Intron 4 of 22 ENST00000294304.12 NP_002326.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP5ENST00000294304.12 linkc.884-4T>C splice_region_variant, intron_variant Intron 4 of 22 1 NM_002335.4 ENSP00000294304.6
LRP5ENST00000529993.5 linkn.884-4T>C splice_region_variant, intron_variant Intron 4 of 22 1 ENSP00000436652.1

Frequencies

GnomAD3 genomes
AF:
0.467
AC:
70891
AN:
151690
Hom.:
18618
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.694
Gnomad AMI
AF:
0.642
Gnomad AMR
AF:
0.496
Gnomad ASJ
AF:
0.389
Gnomad EAS
AF:
0.111
Gnomad SAS
AF:
0.174
Gnomad FIN
AF:
0.260
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.406
Gnomad OTH
AF:
0.446
GnomAD2 exomes
AF:
0.378
AC:
94789
AN:
250626
AF XY:
0.360
show subpopulations
Gnomad AFR exome
AF:
0.699
Gnomad AMR exome
AF:
0.535
Gnomad ASJ exome
AF:
0.382
Gnomad EAS exome
AF:
0.106
Gnomad FIN exome
AF:
0.270
Gnomad NFE exome
AF:
0.404
Gnomad OTH exome
AF:
0.400
GnomAD4 exome
AF:
0.395
AC:
576786
AN:
1461444
Hom.:
121308
Cov.:
47
AF XY:
0.386
AC XY:
280961
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.712
AC:
23832
AN:
33474
American (AMR)
AF:
0.531
AC:
23731
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.388
AC:
10151
AN:
26132
East Asian (EAS)
AF:
0.0935
AC:
3712
AN:
39700
South Asian (SAS)
AF:
0.172
AC:
14866
AN:
86230
European-Finnish (FIN)
AF:
0.275
AC:
14664
AN:
53384
Middle Eastern (MID)
AF:
0.446
AC:
2561
AN:
5736
European-Non Finnish (NFE)
AF:
0.413
AC:
459061
AN:
1111700
Other (OTH)
AF:
0.401
AC:
24208
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
18208
36416
54623
72831
91039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14102
28204
42306
56408
70510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.468
AC:
70973
AN:
151808
Hom.:
18654
Cov.:
29
AF XY:
0.456
AC XY:
33840
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.694
AC:
28695
AN:
41366
American (AMR)
AF:
0.496
AC:
7559
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.389
AC:
1346
AN:
3464
East Asian (EAS)
AF:
0.110
AC:
569
AN:
5162
South Asian (SAS)
AF:
0.174
AC:
838
AN:
4814
European-Finnish (FIN)
AF:
0.260
AC:
2747
AN:
10546
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.406
AC:
27573
AN:
67900
Other (OTH)
AF:
0.442
AC:
932
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1755
3509
5264
7018
8773
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.436
Hom.:
6570
Bravo
AF:
0.503
Asia WGS
AF:
0.197
AC:
692
AN:
3478
EpiCase
AF:
0.420
EpiControl
AF:
0.417

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 24, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 29, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.5
DANN
Benign
0.66
PhyloP100
-0.25
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000056
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs314776; hg19: chr11-68133035; COSMIC: COSV53714341; API